Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Brain Foundation Netherlands has allocated 300,000 euros for researchers, including Prof Catherine Harmer from Oxford University's Department of Psychiatry, to investigate whether existing smartphone Apps can lead to this reduction in risk.

In the United Kingdom, 1.24 million people suffer from depression annually. For a large proportion of these people, it is not the first time that they have a depressive episode. The relapse into depression is a major problem that occurs in 50 to 75% of people with previous depressive episodes. If depression returns it causes great suffering, loss of social roles, unproductiveness and high costs for society (estimated to be 7.5 billion pounds in the UK), in addition to risk of suicide and the risk of becoming a chronic depressive episode.

Read more (Department of Psychiatry website)

Similar stories

Population-scale study highlights ongoing risk of COVID-19 in some cancer patients despite vaccination

COVID-19 vaccination is effective in most cancer patients, but the level of protection against COVID-19 infection, hospitalisation and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

New reporting guidelines developed to improve AI in healthcare settings

New reporting guidelines, jointly published in Nature Medicine and the BMJ by Oxford researchers, will ensure that early studies on using Artificial Intelligence (AI) to treat real patients will give researchers the information needed to develop AI systems safely and effectively.

Major boost for Oxford’s mission to counter future pandemic threats

The Moh Family Foundation has given a substantial gift to support the work of Oxford University’s Pandemic Sciences Institute, greatly strengthening its ability to identify and counter future pandemic threats and ensure equitable access to treatments and vaccines around the world.

Three NHSBT research units launch at University of Oxford

The NIHR has awarded three new Blood and Transplant Research Units (BTRUs) to the University of Oxford.

Fourth COVID-19 vaccine dose provides stronger immunity boost than third dose, shows UK study

COVID-19 vaccines given as fourth doses in the UK offer excellent boosting immunity protection, according to the latest results from a nationwide NIHR-supported study.